Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Change in Accured Expenses (2016)

Microbot Medical's Change in Accured Expenses history spans 7 years, with the latest figure at $68000.0 for Q4 2016.

  • For the quarter ending Q4 2016, Change in Accured Expenses fell 88.22% year-over-year to $68000.0, compared with a TTM value of $322000.0 through Dec 2016, up 387.88%, and an annual FY2025 reading of $495000.0, down 43.3% over the prior year.
  • Change in Accured Expenses for Q4 2016 was $68000.0 at Microbot Medical, down from $213000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.0 million in Q4 2014, with the low at -$1.6 million in Q1 2015.
  • Average Change in Accured Expenses over 5 years is $208901.0, with a median of $60880.5 recorded in 2014.
  • Biggest YoY gain for Change in Accured Expenses was 685.8% in 2013; the steepest drop was 759.15% in 2013.
  • Tracing MBOT's Change in Accured Expenses over 5 years: stood at $1.2 million in 2012, then soared by 36.57% to $1.6 million in 2013, then soared by 80.46% to $3.0 million in 2014, then plummeted by 80.54% to $577188.0 in 2015, then crashed by 88.22% to $68000.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Change in Accured Expenses are $68000.0 (Q4 2016), $213000.0 (Q3 2016), and $91000.0 (Q2 2016).